Efficacy of Skin Cooling in Reducing Pain Associated With Non-invasive Treatments of Neurofibromatosis Type 1 Cutaneous Neurofibromas
This study will evaluate the effectiveness of skin cooling in increasing tolerability of four treatments in Neurofibromatosis Type 1 Cutaneous Neurofibromas. These treatments are: a 980nm laser, a 755nm laser, radio-frequency injection, and a Kybella injection. Each patient will have a treatment and a control site..
• Adult ≥18 years of age
• Have a diagnosis of NF1 based on germline genetic testing or by meeting ≥ 2 the following criteria:
‣ Family history of NF1
⁃ Six or more light brown (cafe-au-lait) spots on the skin
⁃ Presence of two or more neurofibromas of any type, or one or more plexiform neurofibromas
⁃ Freckling under the arms or in the groin area
⁃ Two or more pigmented, benign bumps on the eye's iris (Lisch nodules)
⁃ A distinctive bony lesion: dysplasia (abnormal growth) of the sphenoid bone behind the eye, or dysplasia of long bones, often in the lower leg
⁃ Tumor on the optic nerve that may interfere with vision
• Patients must be seeking treatment for cNF
• Patients must have ≥ 6 paired cNF (3 to be treated and 3 untreated) that are visible and measure between 2-8mm in size. These must be in areas amenable to treatment and surveillance with digital photography.
• cNF must be located on the trunk, arms or legs of the patient
• Able and willing to comply with all visit, treatment and evaluation schedules and requirements
• Able to understand and provide written informed consent